{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:12:20Z","timestamp":1761945140922,"version":"build-2065373602"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s00393-006-0125-5","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T20:13:38Z","timestamp":1164140018000},"page":"709-724","source":"Crossref","is-referenced-by-count":11,"title":["Labordiagnostik der systemischen Autoimmunerkrankungen","Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses"],"prefix":"10.1007","volume":"65","author":[{"given":"K.","family":"Hartung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-P.","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"125_CR1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526\u20131533","journal-title":"N Engl J Med"},{"key":"125_CR2","unstructured":"Conrad K (Hrsg) (1998) Autoantik\u00f6rper. Update: Clinical Immunology, Vol 8. Pabst Science, Lengerich"},{"key":"125_CR3","unstructured":"Ehrfeld H, Renz M, Hartung K et al. (1994) Rekombinante Ro-, La und U1-n-RNP-Antigene: Nachweis von Autoantik\u00f6rpern mittels ELISA und klinische Assoziationen beim SLE. Z \u00c4rztl Fortbild 88: 495\u2013500"},{"key":"125_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/S0049-0172(03)00133-1","volume":"33","author":"Font","year":"2004","unstructured":"Font J, Cervera R, Ramos-Casals M et al. (2004) Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 33: 217\u2013230","journal-title":"Semin Arthritis Rheum"},{"key":"125_CR5","first-page":"80","volume":"5","author":"Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5: 80\u201393","journal-title":"Arthritis Res Ther"},{"key":"125_CR6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2003.013417","volume":"63","author":"Hoffman","year":"2004","unstructured":"Hoffman IE, Peene I, Meheus L et al. (2004) Specific antinuclear antibodies are associated with clinicaI features in systemic lupus erythematosus. Ann Rheum Dis 63: 1155\u20131158","journal-title":"Ann Rheum Dis"},{"key":"125_CR7","first-page":"a","volume":"conditions","author":"Koopman","year":"2005","unstructured":"Koopman WJ (ed) (2005) Arthritis and allied conditions: a textbook of rheumatology. Williams & Wilkins, Baltimore","journal-title":"Arthritis and allied"},{"key":"125_CR8","unstructured":"Peter JB, Shoenfeld Y (eds) (1996): Autoantibodies. Elsevier, Amsterdam"},{"key":"125_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(93)90063-D","volume":"157","author":"Porcel","year":"1993","unstructured":"Porcel JM, Peakman M, Senaldi G, Vergani D (1993) Methods for assessing complement activation in the clinical immunology laboratory. J Immunol Methods 157: 1\u20139","journal-title":"J Immunol Methods"},{"key":"125_CR10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI2749","volume":"102","author":"Riemekasten","year":"1998","unstructured":"Riemekasten G, Marell J, Trebeljahr G et al. (1998) A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest 102: 754\u2013763","journal-title":"J Clin Invest"},{"key":"125_CR11","doi-asserted-by":"crossref","unstructured":"Tsokos GC (ed) (2004) Complement in autoimmunity. Current directions in autoimmunity, vol 7. Karger, Basel Freiburg New York","DOI":"10.1159\/isbn.978-3-318-01024-4"},{"key":"125_CR12","unstructured":"Wallace DJ, Hahn BH (eds) (2002) Dubois\u2018 Lupus Erythematosus, 6th edn. Williams & Wilkins, Baltimore"},{"key":"125_CR13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/03009740500202664","volume":"34","author":"Wiik","year":"2005","unstructured":"Wiik A (2005) Anti-nuclear antibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 34: 260\u2013268","journal-title":"Scand J Rheumatol"},{"key":"125_CR14","first-page":"2617","volume":"27","author":"Witte","year":"2000","unstructured":"Witte T, Matthias T, Arnett FC et al. and the SLE-Study Group (2000) IgA and IgG autoantibodies against alpha-Fodrin as markers for Sj\u00f6gren\u2019s Syndrome. J Rheumatol 27: 2617\u20132620","journal-title":"J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0125-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-006-0125-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0125-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:29:38Z","timestamp":1559060978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-006-0125-5"}},"subtitle":["Teil\u00a0I: Kollagenosen"],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1007\/s00393-006-0125-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}